Commerce ministry recommends anti-dumping duties on solar cells imported from US, China
Renewable energy ministry may get prime minister-designate, Narendra Modi, to stall move, fearing energy price rise
TRIPS waiver for COVID-19 vaccines, meds just got tougher after US support
Biden administration wants text-based negotiations on a waiver limited to vaccines but no one is complaining
Nigeria’s WTO candidate gets Africa’s backing
Ngozi Okonjo-Iweala, a candidate contesting for director-general at the World Trade Organization, has worked for 25 years at the World Bank &…
WTO finally sides with the US; terms India’s solar conditions ‘inconsistent’
India had appealed against an earlier decision of WTO which favoured the US
India finally gives in on TRIPS waiver
The WTO agreement on a limited patents waiver merely restates exemptions already available under existing rules
India’s time to lead at the WTO
USA’s price suppression and market distortions in cotton is threatening Indian and African producers
WTO decision on access to COVID-19 drugs without strings delayed
Proposal will be formally discussed in March next year, sources say
WTO members agree to discuss proposal to waive patents on COVID-19 technologies
The waiver would increase access to technologies crucial to fighting the pandemic
India, South Africa block attempt to include ‘investment facilitation for development’ agreement at WTO meet
New issues should not be considered for ministerial mandates unless past decisions and unfulfilled mandates were acted upon, states India
‘Compromise’ on TRIPS waiver is a sellout
Tough new conditions emerge in the compromise deal to ease WTO intellectual property barriers to production of COVID-19 medical tools
US wins poultry case against India at WTO
India has been given 12-18 months to implement steps to lift the ban; failing which it would be heavily penalised
Amid protests over agri laws let's look at how some countries support farmers
Every day, 54, mostly developed countries give nearly $2 billion in support to their farmers
COVID-19 vaccine: WTO chief brushes aside TRIPS waiver
Ngozi Okonjo-Iweala offers ‘third way’ to bridge the COVID vaccine shortfall based on more licensing agreements
Commerce ministry may levy heavy dumping duty on solar goods
The move can boost Indian firms facing a setback due to dumping of solar products by China, Taiwan and the US
Decade-old FAO guidelines still the way ahead for food security, says report
No consensus at forums like WTO dangerous for international food security, it adds
‘Unhappy’ India might not block WTO protocol
But wants talks on food security to progress at the same pace as trade facilitation
WTO rules against India's domestic content requirements in solar power
The complaint alleged that the DCR mandate put into place by India discriminated against US exports and favoured Indian manufacturers
Who is really afraid of the TRIPS agreement?
India has not shown the grit to fully use the inbuilt flexibilities in the WTO’s TRIPS pact to protect public health
COVID-19 Vaccine Watch: Appeals made for support on proposal regarding intellectual property
If it is adopted on December 16, IP rights on production and supply of COVID-19 tools will be waived off
Coronavirus vaccines: TRIPS waiver caught in WTO labyrinth
Little change in the position of countries opposing waiver of intellectual property rights; India-South Africa proposal being through hoops …
Agriculture, fisheries take spotlight at WTO meet in Abu Dhabi
India backs permanent solution for public stockholding of food grains even as developing nations attack it
Investments from India to lead growth in East African market
Over the last decade, Africa-India trade has followed the upward trend in South-South trade and investments
China opposes anti-dumping probe on solar panels by the US
Warns US of retaliatory measures
Trade war over wind energy heats up between US and China
Third complaint against Chinese companies flouting rules filed. Probe underway
Indian company gets licence to manufacture and sell patented cancer drug
This is the first-ever compulsory licence given to a generic drug company